Mergers & Acquisitions Mergers & Acquisitions

Danaher’s purchase of GE Healthcare biopharma unit wins conditional antitrust clearance in China (English version)

By MLex Staff
  • 24 Mar 2020 20:25
  • 24 Mar 2020 20:25
Below is an English translation of the decision, provided by MLex. The original decision in Chinese can be found here.
China’s SAMR conditionally clears Danaher’s acquisition of GE biopharma unit

I. Procedures

On April 29, 2019, China’s State Administration for Market Regulation (SAMR) received a notification of the proposed acquisition

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

Latest News